{"id":"NCT00770341","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)","officialTitle":"A Phase III Randomized, Open-labeled Clinical Trial of MK-3009 (Daptomycin) in Patients With Skin and Soft Tissue Infections, Septicemia and Right-sided Infective Endocarditis Caused by MRSA","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09","primaryCompletion":"2010-02","completion":"2010-02","firstPosted":"2008-10-10","resultsPosted":"2011-06-15","lastUpdate":"2017-03-24"},"enrollment":122,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Staphylococcal Infection"],"interventions":[{"type":"DRUG","name":"Daptomycin 4 mg/kg","otherNames":["MK3009"]},{"type":"DRUG","name":"Comparator: vancomycin","otherNames":[]},{"type":"DRUG","name":"Daptomycin 6 mg/kg","otherNames":[]}],"arms":[{"label":"MK-3009 (daptomycin) 4 mg/kg","type":"EXPERIMENTAL"},{"label":"Vancomycin","type":"ACTIVE_COMPARATOR"},{"label":"MK-3009 (daptomycin) 6 mg/kg","type":"EXPERIMENTAL"}],"summary":"The study investigates the efficacy and safety of MK-3009 in participants with skin infections, septicemia and right-sided infective endocarditis (RIE) caused by methicillin-resistant Staphylococcus aureus (MRSA).","primaryOutcome":{"measure":"Efficacy Adjudication Committee (EAC) Assessment of Number of Participants With Clinical Success at Test of Cure (TOC)","timeFrame":"7-14 days for SSTI, 14-42 days for septicemia and right-sided infective endocarditis (RIE)","effectByArm":[{"arm":"MK-3009 (Daptomycin) 4 mg/kg","deltaMin":45,"sd":null},{"arm":"Vancomycin","deltaMin":16,"sd":null},{"arm":"MK-3009 (Daptomycin) 6 mg/kg","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23085743","26072149"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":1},"commonTop":["ALANINE AMINOTRANSFERASE INCREASED","ASPARTATE AMINOTRANSFERASE INCREASED","PYREXIA","BLOOD POTASSIUM INCREASED","C-REACTIVE PROTEIN INCREASED"]}}